- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05472844
The Cohort Study of Pediatric Cataract
September 26, 2022 updated by: Yizhi Liu, Zhongshan Ophthalmic Center, Sun Yat-sen University
This retrospective-prospective bidirectional cohort study aims to observe ocular parameter changes, different surgical/vision recovery strategies and postoperative adverse effects among young children with cataract.
The influence on psychology and cognitive function will be taken into consideration as well.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Pediatric cataract, one of the leading causes of childhood blindness globally, is complex and of great difficulty in treatment.
Pediatric patients with cataract (congenital, traumatic or complicated) are enrolled.
In this study, investigators will compare ocular parameter changes, different surgical/vision timing or recovery strategies and adverse effects among young children (age < 18 yo)before and after cataract surgery.
The influence on psychology and cognitive function will be taken into consideration as well.
The whole blood samples of participants and parents are collected and retained in our biobank for gene sequencing, hoping to explore the genetic factors in association with pathogenesis.
For children received cataract surgery, samples of partial anterior capsular tissue and 1 ml aqueous humor were collected during operation for further analysis.
Multimodal artificial intelligence analyses are performed to establish accurate diagnosis/treatment scheme and disease prediction model.
Study Type
Observational
Enrollment (Anticipated)
5000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhenzhen Liu, PhD
- Phone Number: +020 66618932
- Email: liuzhenzhen@gzzoc.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Recruiting
- Zhongshan Ophthalmic Center
-
Contact:
- Zhenzhen Liu, PhD
- Phone Number: +020 66618932
- Email: liuzhenzhen@gzzoc.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This is a retrospective-prospective bidirectional cohort study.
Patients aged < 18 yo at the 1st visit are enrolled.
Description
Inclusion Criteria:
- aged < 18 yo at the 1st visit unilateral or bilateral cataract agree to participant in this study and sign the informed consent
Exclusion Criteria:
- adults
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Best-corrected visual acuity changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Best-corrected visual acuity changes are measured by visual acuity charts (Teller/Lea symbol/ETDRS chart) every 1 year at scheduled time
|
Baseline and through study completion, an average of 1 year
|
|
Intraocular pressure changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Intraocular pressures are measured by NCT machine
|
Baseline and through study completion, an average of 1 year
|
|
Refractive power changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Refractive power are measured at baseline and every visit at least every 1 year
|
Baseline and through study completion, an average of 1 year
|
|
Ocular biological measurements changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Ocular biological measurements including axial length, corneal keratometry, anterior chamber angle/depth, corneal endothelial cell number and appearance
|
Baseline and through study completion, an average of 1 year
|
|
Incidence changes of postoperative complications
Time Frame: Baseline and through study completion, an average of 1 year
|
Incidence of postoperative complications, such as glaucoma-related adverse, myopic shift, strabismus and anisometropia and so on
|
Baseline and through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other factors changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Sleep, depression, cognitive function are measured by questionnaires.
Self-Rating Scale of Sleep: minimum value-1 point, maximum value-50, and higher scores mean worse outcome.
Hamilton Depression Scale: <7 points-normal, and higher scores mean worse outcome.
Loewenstein Cognitive Assessment: for every question, minimum 1 point, and maximum 4 points.
Higher scores mean worse outcomes.
|
Baseline and through study completion, an average of 1 year
|
|
BMI changes
Time Frame: Baseline and through study completion, an average of 1 year
|
BMI is measured by technicians in every visit
|
Baseline and through study completion, an average of 1 year
|
|
Blood pressure changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Diastolic and systolic blood pressure are measured by technicians in every visit
|
Baseline and through study completion, an average of 1 year
|
|
Stereopsis changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Stereopsis is measured by Randot Stereotest
|
Baseline and through study completion, an average of 1 year
|
|
Optical coherence tomography (OCT) changes
Time Frame: Baseline and through study completion, an average of 1 year
|
Retinal thickness is measured and analyzed by OCT
|
Baseline and through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017 Sep;102(9):853-857. doi: 10.1136/archdischild-2016-310532. Epub 2017 May 2. Erratum In: Arch Dis Child. 2017 Oct;102(10):995.
- Chak M, Wade A, Rahi JS; British Congenital Cataract Interest Group. Long-term visual acuity and its predictors after surgery for congenital cataract: findings of the British congenital cataract study. Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4262-9. doi: 10.1167/iovs.05-1160.
- Long E, Zhang X, Liu Z, Wu X, Tan X, Lin D, Cao Q, Chen J, Lin Z, Wang D, Li X, Li J, Wang J, Li W, Lin H, Chen W, Liu Y. Dynamic response to initial stage blindness in visual system development. Clin Sci (Lond). 2017 Jun 28;131(13):1515-1527. doi: 10.1042/CS20170234. Print 2017 Jul 1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 22, 2022
Primary Completion (ANTICIPATED)
January 1, 2032
Study Completion (ANTICIPATED)
February 1, 2032
Study Registration Dates
First Submitted
June 6, 2022
First Submitted That Met QC Criteria
July 20, 2022
First Posted (ACTUAL)
July 25, 2022
Study Record Updates
Last Update Posted (ACTUAL)
September 27, 2022
Last Update Submitted That Met QC Criteria
September 26, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022KYPJ099
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cataract
-
Wenzhou Medical UniversityUnknown
-
Medical University of South CarolinaAlcon ResearchCompleted
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Cairo UniversityCompletedGlaucoma Following Pediatric Cataract SurgeryEgypt
-
Jin YangRecruitingCongenital Cataract | Pediatric CataractChina
-
Mansoura UniversityEnrolling by invitationPediatric GlaucomaEgypt
-
Evidence Based Cataract Study GroupEye & ENT Hospital of Fudan UniversityRecruitingVisual Outcome | Congenital Cataract | Traumatic Cataract | Pediatric Cataract | Genetic AnticipationChina
-
Sun Yat-sen UniversityActive, not recruitingCongenital Cataract | Glaucoma Secondary | Glaucoma Following Pediatric Cataract Surgery
-
Eye & ENT Hospital of Fudan UniversityCompletedCongenital Cataract | Pediatric CataractChina
-
Yune ZhaoCompletedPediatric Cataract | Capsular Contracture, ImplantChina